New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
TAXUS Libertē Post Approval Study
The TAXUS Libertē Post-Approval Study is an FDA-mandated prospective, multi-center study
designed to collect real-world safety and clinical outcomes in approximately 4,200 patients
receiving one or more TAXUS Liberté Paclitaxel-Eluting Stents and prasugrel as part of a
dual antiplatelet therapy (DAPT) drug regimen.
This study will also contribute patient data to an FDA-requested and industry-sponsored
research study that will evaluate the optimal duration of dual antiplatelet therapy (DAPT
Study).